-
"A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer" published on Molecular Oncology (IF: 6.6)
AnchorDx and the team of Prof. Ping Lan and Prof. Xianrui Wu from The Sixth Affiliated Hospital of Sun Yat-sen University published a paper, "A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer", on Molecular Oncology (IF: 6.6)
-
"Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids" published on Clinical Epigenetics (IF: 5.7)
AchorDx and the research group of Liu Dan and Li Weimin in West China Hospital reported in Clinical Epigenetics (Impact factors: 5.7) Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
-
"A urine‑based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer" was published in Clinical Epigenetics (IF:5.7)
AnchorDx and the team of Prof. Tianxin Lin and Prof. Jian Huang from Sun Yat-sen Memorial Hospital, Sun Yat-sen University, published a paper, "A urine‑based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer", on Clinical Epigenetics (IF: 5.7)
-
"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer" was published in The internationally renowned academic journal The Journal of Clinical Investigation (Impact factor: 15.9)
AnchorDx, together with Tianxin Lin and Jian Huang of Sun Yat-sen Memorial Hospital, Sun Yat-sen University, published a report in The Journal of Clinical Investigation (Impact factors: 15.9) published a clinical research paper on Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.